-
A surgeon who was the director of the liver transplant program at St. Vincent Medical Center in Los Angeles was indicted recently by a federal grand jury for allegedly lying to the national organ transplant network.
-
Site marking to eliminate wrong-site surgery is not required when the incision site is not certain before surgery begins, according to a clarification from The Joint Commission in Oakbrook Terrace, IL.
-
Pendleton Memorial Methodist Hospital in New Orleans pointed out that it had met all local building and safety codes regarding its emergency generators, but that may not be a high-enough standard. The Joint Commission in Oakbrook Terrace, IL, has expectations regarding emergency preparedness that may exceed any local requirements.
-
For three weeks, lawyers representing Kent Hospital in Rhode Island were in Kent County Superior Court in Warwick, RI, battling with the attorneys representing the family of actor James Woods.
-
With the ongoing debate over health care reform, the idea of malpractice tort reform has gotten short shrift, but some analysts are saying the time is right to address out-of-control malpractice risks by instituting a mandatory physician review panel. Others say no, that such a system would inevitably be biased in favor of the health care defendants.
-
A girl was admitted to a psychiatric facility after her parents found evidence of the girl having suicidal thoughts. The parents requested in writing that the hospital not send any records of the admission to the girl's school.
-
A woman presented at two hospital emergency departments (ED) complaining of a number of respiratory symptoms. She was not admitted and was sent home with a prescription.
-
-
The Office of Protocol Research of the University of Texas M.D. Anderson Cancer Center in Houston developed its administrative research-monitoring plan (ARMP) as a simple, user-friendly systematic tool.
-
There are a variety of models for research ethics consultation services (RECS), but a common factor that has made these new ethics boards appealing to top U.S. health officials and foundations is the idea that they can work collaboratively with IRBs to improve human subjects protection, an expert says.
